Tag: Viewpoint Molecular Targeting
Medtech companies merge to form Perspective Therapeutics
Coralville-based Viewpoint Molecular Targeting has formally merged with Isoray Inc. out of Richland, Washington to become Perspective Therapeutics.
The company currently trades on the New...
Viewpoint launches patient enrollment in cancer imaging study
Coralville-based Viewpoint Molecular Targeting Inc., a radiopharmaceutical company developing precision alpha-particle oncology therapeutics and complementary diagnostic imaging agents, has announced it has launched patient...
Viewpoint Molecular receives $2M in SBIR funding
Dr. Michael Schultz, chief science officer with Viewpoint Molecular Targeting LLC in Coralville. CREDIT VMT
By Katharine Carlon
[email protected]
An innovative new method of pinpointÂing the location...